Study Shows Blood-Brain Barrier Model Design Affects How Immune Cells Behave in Parkinson's Disease Research
Researchers comparing two types of human blood-brain barrier (BBB) models found that the architecture of the experimental system — static 2D transwell versus 3D microfluidic chip — produced substantially different results when studying how immune cells interact with the BBB in Parkinson's disease. The study used iPSC-derived BBB models incorporating a Parkinson's-associated genetic mutation (SNCA triplication) and exposed immune cells to forms of alpha-synuclein, a protein central to PD pathology. The findings suggest that conclusions about peripheral immune trafficking in Parkinson's disease may be fundamentally shaped by which laboratory model is used, highlighting the need for physiologically realistic platforms.
A preprint study posted to bioRxiv investigated how peripheral blood mononuclear cells (PBMCs) from Parkinson's disease (PD) patients and healthy controls interact with human blood-brain barrier (BBB) models built on induced pluripotent stem cells (iPSCs). The researchers compared a conventional two-dimensional transwell system with a three-dimensional microfluidic 'brain chip' that incorporates fluid flow, testing the effects of PD immune cell status, an SNCA triplication genotype in endothelial cells, and exposure to alpha-synuclein monomers or preformed fibrils. In the transwell model, the SNCA triplication increased PBMC attachment and selectively enhanced transmigration of PD-derived PBMCs, while preformed fibrils increased attachment but not transmigration. In the microfluidic chip, however, attachment was largely unaffected by genotype or alpha-synuclein exposure, while transmigration increased after alpha-synuclein monomer pre-treatment — a divergent pattern from the transwell results. PBMCs from PD donors consistently showed elevated baseline reactivity and altered endothelial interactions relative to controls across both systems. The authors conclude that biological insights into BBB function are inherently model-dependent, and advocate for complementary, flow-based human BBB platforms to more accurately capture disease-relevant immune trafficking.
What's missing
As a preprint, this study has not yet undergone peer review, and its findings should be interpreted with caution. The study does not report whether the observed differences in immune cell trafficking translate to functional neurological outcomes or disease progression in vivo. The generalizability of results is limited by the use of a single PD-associated mutation (SNCA triplication), which represents a rare familial form of PD rather than the more common sporadic cases. Sample sizes for PD donor PBMCs are not specified in the abstract, making it difficult to assess statistical power. Additionally, the study does not address whether the microfluidic chip or transwell system more accurately recapitulates in vivo human BBB behavior, leaving open the question of which model's findings are more biologically valid.
What different sources said
- bioRxivCenter
Blood-brain barrier model architecture shapes peripheral immune cell trafficking in Parkinson's disease
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.